Company:  ALKERMES PLC. (ALKS)
Form Type:  10-Q
Filing Date:  2/2/2012 
CIK:  0001520262 
Address:  CONNAUGHT HOUSE
1 BURLINGTON ROAD
 
City, State, Zip:  DUBLIN 4,  00000 
Telephone:  00-353-1-772-8000 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$46.28  
Change: 
-0.49 (-1.05%)  
Trade Time: 
Apr 24  
Market Cap: 
$6.68B
Description of Business
The following discussion contains forward-looking statements. Actual results may differ significantly from those projected in the forward-looking statements. See "Cautionary Note Concerning Forward-Looking Statements" on pages 3 and 4 of this Transition Report. Factors that might cause future results to differ materially from those projected in the forward-looking statements also include, but are not limited to, those discussed in "Item 1A�Risk Factors" and elsewhere in this Transition Report. Overview Alkermes plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to research, develop and commercialize, both with partners and on our own, pharmaceutical products that are designed to address unmet medical needs of patients in major therapeutic areas.
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    Ex-31.1 Section 302 Certification of Chief Executive Officer
    PART I. FINANCIAL INFORMATION
      Item 1. Condensed Consolidated Financial Statements:
        BALANCE SHEET
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - ...
      Item 2. Management's Discussion and Analysis of Financial ...
      Item 3. Quantitative and Qualitative Disclosures about ...
      Item 4. Controls and Procedures
    PART II. OTHER INFORMATION
      Item 1. Legal Proceedings
      Item 1A. Risk Factors
      Item 2. Unregistered Sales of Equity Securities and Use of ...
      Item 5. Other Information
      Item 6. Exhibits
    SIGNATURES
  EXHIBIT 31.1
    CERTIFICATIONS
  EXHIBIT 31.2
    CERTIFICATIONS
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO
BROKERAGE PARTNERS